Correction: Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype.

Correction: Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4081815

Similar Items

Correction: Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype
by: The Staff
Published: (2014-01-01)

Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.
by: Wen-Huan Xu, et al.
Published: (2012-01-01)

A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
by: Fei Ma, et al.
Published: (2014-01-01)

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
by: F. Piras, et al.
Published: (2011-11-01)

Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer
by: Soon Auck Hong, et al.
Published: (2018-05-01)

Elevated levels of Dickkopf-1 are associated with β-catenin accumulation and poor prognosis in patients with chondrosarcoma.
by: Changbao Chen, et al.
Published: (2014-01-01)

R-spondin 1/dickkopf-1/beta-catenin machinery is involved in testicular embryonic angiogenesis.
by: Maria Caruso, et al.
Published: (2015-01-01)

Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
by: Fabiola Giudici, et al.
Published: (2019-01-01)

Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer
by: Shannon E. Weeks, et al.
Published: (2021-03-01)

β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.
by: Jinhua Xu, et al.
Published: (2015-01-01)

Regulation of Phenotypic Plasticity in Triple-Negative Breast Cancer
by: D'Amato, Nicholas
Published: (2011)

Update on triple-negative breast cancer: prognosis and management strategies
by: Brouckaert O, et al.
Published: (2012-09-01)

Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.
by: Nicola Ferrari, et al.
Published: (2014-01-01)

MAT2B expression correlates with poor prognosis in triple-negative breast cancer
by: Xu J, et al.
Published: (2019-06-01)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
by: So-Woon Kim, et al.
Published: (2021-08-01)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
by: Sainan Liu, et al.
Published: (2021-05-01)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
by: Xi Cao, et al.
Published: (2021-01-01)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
by: Katarzyna Pogoda, et al.
Published: (2020-01-01)

Immunohistochemical evaluation of Ki-67, Cyclin D1 and β-catenin expression in the subtypes of triple negative breast cancer
by: L N Vashchenko, et al.
Published: (2019-12-01)

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
by: Won-Ji Ryu, et al.
Published: (2020-05-01)

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression
by: Li K, et al.
Published: (2014-06-01)

Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
by: Katsuhiro Yoshikawa, et al.
Published: (2020-01-01)

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
by: Han T, et al.
Published: (2015-07-01)

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer
by: Li Chen, et al.
Published: (2021-04-01)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
by: Sijia Wu, et al.
Published: (2021-01-01)

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
by: Yong Yue, et al.
Published: (2016-01-01)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
by: Hirokazu Tanino, et al.
Published: (2016-01-01)

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
by: Cheang Maggie CU, et al.
Published: (2007-07-01)

Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
by: Fabiola Giudici, et al.
Published: (2019-01-01)

Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
by: Iram Fatima, et al.
Published: (2018-01-01)

MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway
by: Wu R, et al.
Published: (2020-07-01)

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
by: Willy Antoni Abreu de Oliveira, et al.
Published: (2021-07-01)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
by: Alexander Ring, et al.
Published: (2018-12-01)

High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer
by: Xuelu Li, et al.
Published: (2017-09-01)

The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients
by: Li P, et al.
Published: (2016-09-01)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
by: Anna E. M. Bastiaansen, et al.
Published: (2020-12-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
by: E V Karabina, et al.
Published: (2016-06-01)

Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype
by: Soumaya Allouch, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_n3ndghok7rpc71rr3n49n23qtc